SCO-240

N/A

Report date: 2024/09/30 11:02:25
NME

Base Information

Drug NameSCO-240
Drug Alias NameSCO-240
ClassificationSmall molecules
Mechanisms of ActionSomatostatin receptor 5 antagonists
TargetsSomatostatin receptor 5
Therapy Area/IndicationsDiabetes MellitusCholelithiasisCholangitis, Sclerosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co LtdScohia Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesScohia Pharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetes MellitusCholelithiasisCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A